<!--
  Raw HTML backup for 16 CFR 1700
  Source: https://www.ecfr.gov/current/title-16/chapter-II/subchapter-E/part-1700

  This file is a placeholder. Run scripts/scrape_regulations.py to populate
  with actual scraped HTML from eCFR.

  Data was manually compiled for data/regulations.json because scraping
  could not be performed at generation time.
-->
<!DOCTYPE html>
<html>
<head><title>16 CFR Part 1700 - Poison Prevention Packaging</title></head>
<body>
<h1>Part 1700 â€” Poison Prevention Packaging</h1>

<h2>Sec. 1700.1 Definitions.</h2>
<p>As used in this part: (a) &quot;Special packaging&quot; means packaging that is designed or constructed to be significantly difficult for children under 5 years of age to open or obtain a toxic or harmful amount of the substance contained therein within a reasonable time and not difficult for normal adults to use properly, but does not mean packaging which all such children cannot open or obtain a toxic or harmful amount within a reasonable time.</p>

<h2>Sec. 1700.14 Substances requiring special packaging.</h2>
<p>(a) The Commission has determined that the degree or nature of the hazard to children in the availability of the following substances, by reason of their packaging, is such that special packaging meeting the requirements of Sec. 1700.20(a) is required to protect children from serious personal injury or serious illness resulting from handling, using, or ingesting such substances. These include:</p>
<ol>
<li>Aspirin and aspirin-containing preparations for human use.</li>
<li>Furniture polish containing petroleum distillates.</li>
<li>Methyl salicylate (oil of wintergreen) preparations.</li>
<li>Controlled substances (Schedule II-IV).</li>
<li>Sodium and potassium hydroxide preparations.</li>
<li>Turpentine-containing preparations.</li>
<li>Kindling and/or illuminating preparations (e.g., charcoal lighter fluid).</li>
<li>Methanol (methyl alcohol) preparations.</li>
<li>Sulfuric acid preparations.</li>
<li>Prescription drugs for human use.</li>
<li>Ethylene glycol preparations.</li>
<li>Iron-containing drugs and dietary supplements.</li>
<li>Dietary supplements containing certain substances.</li>
<li>Acetaminophen preparations.</li>
<li>Diphenhydramine preparations.</li>
<li>Ibuprofen preparations.</li>
<li>Loperamide preparations.</li>
<li>Mouthwash containing ethanol.</li>
<li>Ketoprofen preparations.</li>
<li>Naproxen preparations.</li>
<li>Lidocaine preparations in concentration &gt; 5mg.</li>
<li>Dibucaine preparations.</li>
<li>Minoxidil preparations.</li>
<li>Over-the-counter drug preparations containing methacrylic acid.</li>
<li>Imidazoline-containing preparations.</li>
<li>Low-viscosity hydrocarbons.</li>
<li>Nicotine-containing preparations for human use.</li>
<li>Second generation anticoagulant rodenticide products.</li>
</ol>

<h2>Sec. 1700.15 Poison prevention packaging standards.</h2>
<p>(a) In accordance with the act, the Commission has established requirements for the special packaging of hazardous household substances. The special packaging must meet child-resistant effectiveness specifications and must also comply with the applicable adult-use effectiveness specifications.</p>
<p>(b) The standards require that the packaging be tested in accordance with the protocols set forth in Sec. 1700.20.</p>

<h2>Sec. 1700.20 Testing procedure for special packaging.</h2>
<p>(a) Child-resistant effectiveness test. Special packaging shall be tested by sequential pairs of children to determine child resistance. The test requires 200 children between the ages of 42 and 51 months. The packaging passes the child-resistant test if not more than 20 percent of the children open it in the first 5-minute test period and not more than 20 percent open it in the total 10-minute test period.</p>
<p>(b) Adult-use effectiveness test. Special packaging shall also be tested to ensure that normal adults can open and close the packaging. The packaging passes the adult test if at least 90 percent of adults can open and properly close the package within 5 minutes.</p>

</body>
</html>
